Center for Acute Care Nephrology, Cincinnati Children's Hospital and Medical Center, University of Cincinnati, Cincinnati, Ohio; Division of Pediatric Critical Care, Cincinnati Children's Hospital and Medical Center, University of Cincinnati, Cincinnati, Ohio.
Division of Pediatric Critical Care, Cincinnati Children's Hospital and Medical Center, University of Cincinnati, Cincinnati, Ohio.
J Am Coll Cardiol. 2014 Dec 30;64(25):2753-62. doi: 10.1016/j.jacc.2014.09.066.
Increases in serum creatinine (ΔSCr) from baseline signify acute kidney injury (AKI) but offer little granular information regarding its characteristics. The 10th Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) suggested that combining AKI biomarkers would provide better precision for AKI course prognostication.
This study investigated the value of combining a functional damage biomarker (plasma cystatin C [pCysC]) with a tubular damage biomarker (urine neutrophil gelatinase-associated lipocalin [uNGAL]), forming a composite biomarker for prediction of discrete characteristics of AKI.
Data from 345 children after cardiopulmonary bypass (CPB) were analyzed. Severe AKI was defined as Kidney Disease Global Outcomes Initiative stages 2 to 3 (≥100% ΔSCr) within 7 days of CPB. Persistent AKI lasted >2 days. SCr in reversible AKI returned to baseline ≤48 h after CPB. The composite of uNGAL (>200 ng/mg urine Cr = positive [+]) and pCysC (>0.8 mg/l = positive [+]), uNGAL+/pCysC+, measured 2 h after CPB initiation, was compared to ΔSCr increases of ≥50% for correlation with AKI characteristics by using predictive probabilities, likelihood ratios (LR), and area under the curve receiver operating curve (AUC-ROC) values [Corrected].
Severe AKI occurred in 18% of patients. The composite uNGAL+/pCysC+ demonstrated a greater likelihood than ΔSCr for severe AKI (+LR: 34.2 [13.0:94.0] vs. 3.8 [1.9:7.2]) and persistent AKI (+LR: 15.6 [8.8:27.5] versus 4.5 [2.3:8.8]). In AKI patients, the uNGAL-/pCysC+ composite was superior to ΔSCr for prediction of transient AKI. Biomarker composites carried greater probability for specific outcomes than ΔSCr strata.
Composites of functional and tubular damage biomarkers are superior to ΔSCr for predicting discrete characteristics of AKI.
血清肌酐(ΔSCr)从基线升高表示急性肾损伤(AKI),但对其特征几乎没有提供详细信息。急性透析质量倡议(ADQI)第十次共识会议建议,将 AKI 生物标志物结合起来,将为 AKI 病程预后提供更好的精度。
本研究探讨了将功能损伤生物标志物(血浆胱抑素 C [pCysC])与管状损伤生物标志物(尿中性粒细胞明胶酶相关脂质运载蛋白 [uNGAL])结合起来,形成一种复合生物标志物,用于预测 AKI 的离散特征的价值。
分析了 345 例体外循环(CPB)后儿童的数据。严重 AKI 定义为 CPB 后 7 天内肾脏疾病全球倡议(KDIGO)分期 2 至 3 级(≥100% ΔSCr)。持续性 AKI 持续时间超过 2 天。可逆性 AKI 的 SCr 在 CPB 后 48 小时内恢复至基线≤48 h。CPB 开始后 2 小时测量的 uNGAL(>200ng/mg 尿 Cr = 阳性 [+])和 pCysC(>0.8mg/l = 阳性 [+])的复合 uNGAL+/pCysC+,与通过使用预测概率、似然比(LR)和曲线下面积接收者操作曲线(AUC-ROC)值 [校正]与 AKI 特征的 ΔSCr 增加相关联。
18%的患者发生严重 AKI。复合 uNGAL+/pCysC+与 ΔSCr 相比,发生严重 AKI 的可能性更大(+LR:34.2[13.0:94.0]比 3.8[1.9:7.2])和持续性 AKI(+LR:15.6[8.8:27.5]比 4.5[2.3:8.8])。在 AKI 患者中,与 ΔSCr 相比,uNGAL-/pCysC+复合对短暂性 AKI 的预测更为优越。生物标志物复合比 ΔSCr 层具有更大的特定结果概率。
功能和管状损伤生物标志物的组合优于 ΔSCr 预测 AKI 的离散特征。